CCP peptide acetate
Code | Size | Price |
---|
TAR-TP1409L-1mg | 1mg | £229.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1409L-5mg | 5mg | £443.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1409L-10mg | 10mg | £701.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1409L-25mg | 25mg | £1,067.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1409L-50mg | 50mg | £1,564.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1409L-100mg | 100mg | £2,311.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
CCP peptide acetate is a synthetic cyclic citrullinated peptide (CCP). CCP peptide acetate can be used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide acetate functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA).
CAS:
TP1409L
Molecular Weight:
2401.52
Purity:
0.98
SMILES:
O=C([C@H](CSSC[C@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@](NC([C@@H](NC([C@@H](NC([C@@H](NC1=O)CCC(N)=O)=O)CCC(O)=O)=O)CO)=O)([H])[C@H](O)C)=O)CCCNC(N)=O)=O)=O)CCCNC(N)=N)=O)CO)=O)CCCNC(N)=N)=O)=O)CCCNC(N)=N)=O)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(NCC(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)NC([C@H](CCC(N)=O)NC([C@@H](N)CC2=CN=CN2)=O)=O)N[C@H]1CC3=CN=CN3.CC(O)=O
References
S?derlin MK, et al. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol. 2004;33(3):185-8.
Puszczewicz M, et al. Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis. Arch Med Sci. 2011 Apr;7(2):189-94.
Schellekens GA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000 Jan;43(1):155-63.